MTF Biologics Receives Physician Preference Management Supplier of the Year Award from Vizient

EDISON, N.J.--(BUSINESS WIRE)--MTF Biologics has been awarded the Physician Preference Management Supplier of the Year Award from Vizient, Inc., the largest member-driven health care performance improvement company in the country. The award was presented in a virtual format Sept. 15 at the 2020 Vizient Connections Education Summit.

The award honors MTF Biologics for Physician Preference Management Supplier of the Year Award in 2019.

“It is an honor to be recognized by Vizient for this award,” said Tom Shaffer, Executive Vice-President Global Sales, Marketing and Business Development. “One of MTF Biologics’ Core Values is to provide exceptional customer service and this award is an acknowledgement of the hard work of so many individuals within our organization to deliver on that promise to all Vizient members.”

“We are pleased to recognize MTF Biologics as our supplier of the year for Physician Preference Supplier of the Year. Collaboration and a commitment to service excellence is the foundational criteria for this award,” said Cathy Denning, group senior vice president, sourcing operations, analytics and center of excellence for Vizient. “This award recognizes their achievements in these critical areas, which enable Vizient’s members to meet their organizational goals for supply chain efficiency and cost management.”

About MTF Biologics
MTF Biologics is a global nonprofit organization on the forefront of saving and healing lives through innovations in tissue and organ donation, transplantation, and research. We collaborate with leading physicians, scientists, and experts in tissue and organ recovery to honor donated gifts, serve patients and advance science. We create the highest quality and safest tissue grafts, and fund clinicians and researchers furthering the science of transplantation. Our subsidiary, International Institute for the Advancement of Medicine (IIAM), provides non-transplantable organs and tissues to the medical research community for purposes of combatting and curing disease. Our subsidiary, Statline, offers specialized communications and technology expertise to organ, tissue and eye procurement organizations, as well as the hospitals and patients they serve. Our sister organization, Deutsches Institute fur Zell-Und Gewebeersatz (DIZG), expands our reach in Europe. For more information, visit www.mtfbiologics.org.